UTHR
UNITED THERAPEUTICS CORP (UTHR.O: Quote, Profile, Research): * Third quarter earnings per
share $0.66 * Third quarter revenue rose 46 percent to $59
million * Reuters Estimates third quarter earnings per share
view $0.32, revenue view $50.88 million * Says increases in
revenue and gross margins due to growth in sales of lead
product, Remodulin
posted by Gordengekko at 8:14 AM
0 Comments:
Post a Comment
<< Home